Mycoplasma hominis impacts gene expression in Trichomonas vaginalis

Parasitol Res. 2018 Mar;117(3):841-847. doi: 10.1007/s00436-018-5761-6. Epub 2018 Jan 24.

Abstract

In Europe, up to 90% of isolated Trichomonas vaginalis strains are naturally infected with Mycoplasma hominis, a facultative pathogen of the human genital tract. The consequences of this endosymbiosis are not yet well understood. The aim of the current study was to evaluate the impact of natural and artificial infections with M. hominis on the RNA expression levels of metronidazole susceptibility-associated genes of T. vaginalis. Three T. vaginalis strains (TVSS10-, TVSS25-, G3) without M. hominis, as well as the same strains naturally (TVSS10+, TVSS25+) and artificially (G3-MhSS25, TVSS25-MhSS25) infected with M. hominis, were investigated for their expression profiles of three genes associated with metronidazole resistance (ferredoxin, flavin reductase 1 and pyruvate:ferredoxin oxidoreductase). The minimal inhibitory concentrations (MICs) of metronidazole were evaluated for all combinations and the respective M. hominis-free T. vaginalis strains were used as controls. The sole presence of M. hominis led to a down-regulation of metronidazole susceptibility-associated genes in all T. vaginalis strains tested. Interestingly, the effect was more prominent in the artificial symbioses. Moreover, a twofold enhancement of metronidazole tolerability was observed in three infected T. vaginalis strains, compared to the respective strains without M. hominis. In conclusion, M. hominis had an impact on gene expression in all T. vaginalis strains and on metronidazole MIC in all but one strain tested.

Keywords: Mycoplasma hominis; PFOR; Symbiosis; Trichomonas vaginalis; mRNA.

MeSH terms

  • Antiprotozoal Agents / pharmacology
  • Down-Regulation
  • Drug Resistance / drug effects
  • Europe
  • Gene Expression Regulation
  • Metronidazole / pharmacology
  • Microbial Sensitivity Tests
  • Mycoplasma hominis / physiology*
  • Symbiosis
  • Trichomonas vaginalis / drug effects
  • Trichomonas vaginalis / genetics*
  • Trichomonas vaginalis / microbiology*

Substances

  • Antiprotozoal Agents
  • Metronidazole